119 related articles for article (PubMed ID: 18374571)
1. Design of high-affinity peptide conjugates with optimized fluorescence quantum yield as markers for small peptide transporter PEPT1 (SLC15A1).
Bahadduri PM; Ray A; Khandelwal A; Swaan PW
Bioorg Med Chem Lett; 2008 Apr; 18(8):2555-7. PubMed ID: 18374571
[TBL] [Abstract][Full Text] [Related]
2. Human dipeptide transporter, hPEPT1, stably transfected into Chinese hamster ovary cells.
Covitz KM; Amidon GL; Sadée W
Pharm Res; 1996 Nov; 13(11):1631-4. PubMed ID: 8956326
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the effect of ethanol's toxic metabolite acetaldehyde on the gastrointestinal oligopeptide transporter, PEPT1: in vitro and in vivo studies.
Fisher SJ; Lee IJ; Swaan PW; Eddington ND
Alcohol Clin Exp Res; 2008 Jan; 32(1):162-70. PubMed ID: 18028524
[TBL] [Abstract][Full Text] [Related]
4. In vitro and pharmacophore-based discovery of novel hPEPT1 inhibitors.
Ekins S; Johnston JS; Bahadduri P; D'Souza VM; Ray A; Chang C; Swaan PW
Pharm Res; 2005 Apr; 22(4):512-7. PubMed ID: 15846457
[TBL] [Abstract][Full Text] [Related]
5. Role of the intestinal peptide transporter PEPT1 in oseltamivir absorption: in vitro and in vivo studies.
Poirier A; Belli S; Funk C; Otteneder MB; Portmann R; Heinig K; Prinssen E; Lazic SE; Rayner CR; Hoffmann G; Singer T; Smith DE; Schuler F
Drug Metab Dispos; 2012 Aug; 40(8):1556-65. PubMed ID: 22584254
[TBL] [Abstract][Full Text] [Related]
6. Peptide transporter substrate identification during permeability screening in drug discovery: comparison of transfected MDCK-hPepT1 cells to Caco-2 cells.
Balimane PV; Chong S; Patel K; Quan Y; Timoszyk J; Han YH; Wang B; Vig B; Faria TN
Arch Pharm Res; 2007 Apr; 30(4):507-18. PubMed ID: 17489369
[TBL] [Abstract][Full Text] [Related]
7. Functional characterization of a cloned pig intestinal peptide transporter (pPepT1).
Klang JE; Burnworth LA; Pan YX; Webb KE; Wong EA
J Anim Sci; 2005 Jan; 83(1):172-81. PubMed ID: 15583057
[TBL] [Abstract][Full Text] [Related]
8. A quantitative structure-activity relationship for translocation of tripeptides via the human proton-coupled peptide transporter, hPEPT1 (SLC15A1).
Omkvist DH; Larsen SB; Nielsen CU; Steffansen B; Olsen L; Jørgensen FS; Brodin B
AAPS J; 2010 Sep; 12(3):385-96. PubMed ID: 20449699
[TBL] [Abstract][Full Text] [Related]
9. CHO/hPEPT1 cells overexpressing the human peptide transporter (hPEPT1) as an alternative in vitro model for peptidomimetic drugs.
Han HK; Rhie JK; Oh DM; Saito G; Hsu CP; Stewart BH; Amidon GL
J Pharm Sci; 1999 Mar; 88(3):347-50. PubMed ID: 10052994
[TBL] [Abstract][Full Text] [Related]
10. The extracellular pH dependency of transport activity by human oligopeptide transporter 1 (hPEPT1) expressed stably in Chinese hamster ovary (CHO) cells: a reason for the bell-shaped activity versus pH.
Fujisawa Y; Tateoka R; Nara T; Kamo N; Taira T; Miyauchi S
Biol Pharm Bull; 2006 May; 29(5):997-1005. PubMed ID: 16651734
[TBL] [Abstract][Full Text] [Related]
11. Butyrate transcriptionally enhances peptide transporter PepT1 expression and activity.
Dalmasso G; Nguyen HT; Yan Y; Charrier-Hisamuddin L; Sitaraman SV; Merlin D
PLoS One; 2008 Jun; 3(6):e2476. PubMed ID: 18575574
[TBL] [Abstract][Full Text] [Related]
12. A fluorescent hPept1 transporter substrate for uptake screening.
Landowski CP; Han HK; Lee KD; Amidon GL
Pharm Res; 2003 Nov; 20(11):1738-45. PubMed ID: 14661916
[TBL] [Abstract][Full Text] [Related]
13. Interactions of a nonpeptidic drug, valacyclovir, with the human intestinal peptide transporter (hPEPT1) expressed in a mammalian cell line.
Guo A; Hu P; Balimane PV; Leibach FH; Sinko PJ
J Pharmacol Exp Ther; 1999 Apr; 289(1):448-54. PubMed ID: 10087037
[TBL] [Abstract][Full Text] [Related]
14. Effect of ionization on the variable uptake of valacyclovir via the human intestinal peptide transporter (hPepT1) in CHO cells.
Balimane P; Sinko P
Biopharm Drug Dispos; 2000 Jul; 21(5):165-74. PubMed ID: 11180195
[TBL] [Abstract][Full Text] [Related]
15. Functional role of the intracellular loop linking transmembrane domains 6 and 7 of the human dipeptide transporter hPEPT1.
Xu L; Li Y; Haworth IS; Davies DL
J Membr Biol; 2010 Dec; 238(1-3):43-9. PubMed ID: 21104182
[TBL] [Abstract][Full Text] [Related]
16. Construction, identification and application of HeLa cells stably transfected with human PEPT1 and PEPT2.
Guo X; Meng Q; Liu Q; Wang C; Sun H; Kaku T; Liu K
Peptides; 2012 Apr; 34(2):395-403. PubMed ID: 22369721
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of supramolecular polyrotaxane-dipeptide conjugates on digested peptide uptake via intestinal human peptide transporter.
Yui N; Ooya T; Kawashima T; Saito Y; Tamai I; Sai Y; Tsuji A
Bioconjug Chem; 2002; 13(3):582-7. PubMed ID: 12009949
[TBL] [Abstract][Full Text] [Related]
18. Development of a QSAR model for binding of tripeptides and tripeptidomimetics to the human intestinal di-/tripeptide transporter hPEPT1.
Andersen R; Jørgensen FS; Olsen L; Våbenø J; Thorn K; Nielsen CU; Steffansen B
Pharm Res; 2006 Mar; 23(3):483-92. PubMed ID: 16489544
[TBL] [Abstract][Full Text] [Related]
19. Affinity prediction for substrates of the peptide transporter PepT1.
Bailey PD; Boyd CA; Collier ID; George JP; Kellett GL; Meredith D; Morgan KM; Pettecrew R; Price RA
Chem Commun (Camb); 2006 Jan; (3):323-5. PubMed ID: 16391748
[TBL] [Abstract][Full Text] [Related]
20. A novel hPepT1 stably transfected cell line: establishing a correlation between expression and function.
Herrera-Ruiz D; Faria TN; Bhardwaj RK; Timoszyk J; Gudmundsson OS; Moench P; Wall DA; Smith RL; Knipp GT
Mol Pharm; 2004; 1(2):136-44. PubMed ID: 15832510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
